相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Temozolomide in aggressive pituitary adenomas and carcinomas
Leon D. Ortiz et al.
CLINICS (2012)
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Camille Baudry et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4-and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours
U. Ploeckinger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Differential Expression of Somatostatin Receptor Subtype 1-5 Proteins in Numerous Human Normal Tissues
N. Unger et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2012)
Potential Role for Retinoic Acid in Patients with Cushing's Disease
Francesca Pecori Giraldi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Medical Management of Persistent and Recurrent Cushing Disease
Maria Fleseriu
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
Annamaria Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Medical management of Cushing's disease: what is the future?
Maria Fleseriu et al.
PITUITARY (2012)
The Calcium-Sensing Receptor: A Molecular Perspective
Aaron L. Magno et al.
ENDOCRINE REVIEWS (2011)
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Hidenori Fukuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Effect of SOM230 (Pasireotide) on Corticotropic Cells: Action in Dogs with Cushing's Disease
Victor Castillo et al.
NEUROENDOCRINOLOGY (2011)
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
Troy H. Dillard et al.
PITUITARY (2011)
EFFICACY OF CABERGOLINE IN UNCURED (PERSISTENT OR RECURRENT) CUSHING DISEASE AFTER PITUITARY SURGICAL TREATMENT WITH OR WITHOUT RADIOTHERAPY
Anurag R. Lila et al.
ENDOCRINE PRACTICE (2010)
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
Marco Losa et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Ariane Godbout et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
H. Bode et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Zachary M. Bush et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Epidemiology of Cushing's Syndrome
Charlotte Steffensen et al.
NEUROENDOCRINOLOGY (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Beverly M. K. Biller et al.
BMC ENDOCRINE DISORDERS (2010)
Merits and pitfalls of mifepristone in Cushing's syndrome
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
M. Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome
C. de Bruin et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly
Robert D. Murray et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
Chirag G. Patil et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma
Marleen Kars et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement
B. M. K. Biller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Somatostatin and somatostatin receptors in Cushing's disease
Leo J. Hofland
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy
Kalman Kovacs et al.
ACTA NEUROPATHOLOGICA (2008)
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine Agonists
Gregor Simonis et al.
MOVEMENT DISORDERS (2007)
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours
Annamaria Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas
Joost van der Hoek et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Dopamine agonists and the risk of cardiac-valve regurgitation
Rene Schade et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Rationale for the use of somatostatin analogs as antitumor agents
C. Susini et al.
ANNALS OF ONCOLOGY (2006)
The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
Dalia L. Batista et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Retinoic acid as a novel medical therapy for Cushing's disease in dogs
Victor Castillo et al.
ENDOCRINOLOGY (2006)
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action
D Giacomini et al.
ENDOCRINOLOGY (2006)
α1-adrenergic receptor antagonists:: Novel therapy for pituitary adenomas
MA Fernando et al.
MOLECULAR ENDOCRINOLOGY (2005)
Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance
AB Atkinson et al.
CLINICAL ENDOCRINOLOGY (2005)
Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells
J van der Hoek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
LJ Hofland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Opportunities in somatostatin research: Biological, chemical and therapeutic aspects
G Weckbecker et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Localization of messenger ribonucleic acids for somatostatin receptor subtypes (sstr1-5) in the rat adrenal gland
AM O'Carroll
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
C Bruns et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Retinoic acid prevents experimental Cushing syndrome
M Páez-Pereda et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Dopamine D2 receptor gene expression in human adenohypophysial adenomas
L Stefaneanu et al.
ENDOCRINE (2001)
Novel long-acting somatostatin analog with endocrine selectivity: Potent suppression of growth hormone but not of insulin
M Afargan et al.
ENDOCRINOLOGY (2001)
分享论文
